Flank Pain as a First Symptom of a Diffuse Midline Glioma

被引：1
|
作者：
Bassa, Burc [1 ]
Battmann, Achim [2 ]
Craemer, Eva Maria [1 ]
Meyding-Lamade, Uta [1 ]
机构：
[1] Krankenhaus NW Frankfurt, Dept Neurol, Frankfurt, Germany
[2] Krankenhaus NW Frankfurt, Dept Pathol, Frankfurt, Germany
来源：
CASE REPORTS IN NEUROLOGY | 2023年 / 15卷 / 01期
关键词：
Midline glioma; Spinal cord tumors; Acute paraparesis; K27M mutation; PROGNOSIS;
D O I：
10.1159/000528311
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Diffuse midline gliomas are a new entity in the WHO Classification of Tumors of the Central Nervous System, corresponding to grade 4 gliomas. The diagnostic pathognomonic feature is the presence of a H3K27M mutation. Although mainly seen in children, cases in adults have also been reported. The symptoms are highly variable and usually dependent on the location and extent of spinal cord compression.
引用
收藏
页码：1 / 5
页数：5
相关论文
共 50 条
  • [31] An unexpected disease course for a patient with diffuse midline glioma
    Malalasekera, Vajiranee S.
    D'Arcy, Colleen E.
    Mignone, Cristina
    Wray, Alison C.
    Nazarian, Javad
    Freeman, Jeremy L.
    Hansford, Jordan R.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (10)
  • [32] TRIPTOLIDE AS A POTENTIALLY PROMISING THERAPY FOR DIFFUSE MIDLINE GLIOMA
    Ciani, Ludovica
    Laternser, Sandra
    Kritzer, Bettina
    Hasler, Kerstin
    Przystal, Justyna M.
    Velagapudi, Mohana R.
    Alonso, Marta M.
    Zalacain, Marta
    Muller, Sabine
    Nazarian, Javad
    NEURO-ONCOLOGY, 2023, 25
  • [33] RETROSPECTIVE ANALYSES OF CLINICAL CHARACTERISTICS OF DIFFUSE MIDLINE GLIOMA
    Miyashita, K.
    Sabit, H.
    Kinoshita, M.
    Nakada, M.
    NEURO-ONCOLOGY, 2017, 19 : 89 - 89
  • [34] Correction to: Prognostic factors analysis of diffuse midline glioma
    Jing Jiang
    Wen-bin Li
    Shao-wen Xiao
    Journal of Neuro-Oncology, 2024, 167 : 293 - 293
  • [35] A NOVEL THERAPEUTIC ANTIBODY TARGETING DIFFUSE MIDLINE GLIOMA
    Balakrishnan, Illango
    Madhavan, Krishna
    Pierce, Angela
    Venkataraman, Sujatha
    Vibhakar, Rajeev
    NEURO-ONCOLOGY, 2022, 24 : 220 - 220
  • [36] CAR T cell therapies for diffuse midline glioma
    Thomas, Bryce C.
    Staudt, Dilana E.
    Douglas, Alicia M.
    Monje, Michelle
    Vitanza, Nicholas A.
    Dun, Matthew D.
    TRENDS IN CANCER, 2023, 9 (10): : 791 - 804
  • [37] METABOLIC REPROGRAMMING AS A RESISTANCE MECHANISM IN DIFFUSE MIDLINE GLIOMA
    Neyazi, Sina
    Gowda, Pruthvi
    Frederico, Stephen C.
    Nguyen, Cuong M.
    Trissal, Maria C.
    Portero, Erika P.
    Haley-Read, John-Paul
    Anderson, Emily P.
    Thomas, Craig J.
    Danial, Nika N.
    Filbin, Mariella G.
    NEURO-ONCOLOGY, 2024, 26
  • [38] The role of brainstem biopsy and targeted therapies in pediatric diffuse midline glioma/diffuse intrinsic pontine glioma
    Sheikh, Shehryar R.
    Recinos, Violette M. R.
    Thompson, Eric M.
    Mangum, Ross
    Wright-Nadkarni, Mariah
    Gampel, Bradley
    Patel, Neha J.
    Natl Pediat Canc Fdn NPCF Cent Nervous Syst Task Force
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [39] SEVERE FLANK PAIN AS THE PREDOMINANT SYMPTOM OF IGA NEPHROPATHY
    PALLER, MS
    DANIELS, BS
    HOSTETTER, TH
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1989, 13 (06) : 494 - 496
  • [40] THE INTERNATIONAL DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)/DIFFUSE MIDLINE GLIOMA (DMG) REGISTRY AND REPOSITORY (IDIPGR) EXPANSION
    Torontali, Marianne
    Doughman, Renee
    Chaney, Brooklyn
    Black, Katie
    Asher, Anthony
    Rupert, Andrew
    Fuller, Christine
    Leach, James
    Jones, Blaise
    Fouladi, Maryam
    DeWire, Mariko
    NEURO-ONCOLOGY, 2020, 22 : 321 - 322
12345